arrow
S

Sabrina Y. Camp

broad institute of mit and harvard
H指数:9
被引数:732

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic correlates of clinical CAR T cell activity

临床CAR T细胞活性的基因组相关性

2026-07-240
PRE
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss

单细胞表观遗传图谱揭示了一种与不良预后和BAP1缺失相关的ccRCC肿瘤内干扰素应答程序。

2026-02-200
OA
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity
2026-01-210
PRE
A context-augmented large language model for accurate precision oncology medicine recommendations

一种用于精准肿瘤学医学推荐的上下文增强大型语言模型

2026-01-150
OAAI
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

早期激素受体阳性乳腺癌在抗PD-1和化疗治疗期间细胞的重编程

2025-11-280
OAAI
Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma

髓系细胞介导干扰素驱动的抗免疫疗法作用于晚期肾细胞癌

Immunity
IF26.3
2025-10-310
OAAI
fusion derived oncogenic programs shape the immune landscape in translocation renal cell carcinoma

融合衍生致癌程序塑造易位性肾细胞癌的免疫景观

2025-10-010
OAAI
Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma

原发性与转移性食管腺癌不同临床阶段中的细胞状态与微环境

2025-06-100
OA
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy

HIF调节多种翻译的内源性逆转录病毒:对癌症免疫治疗的启示

CELL
IF42.5
2025-02-010
OAAI
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
2023-03-022
OA
A patient-driven clinicogenomic partnership for metastatic prostate cancer

转移性前列腺癌的患者驱动的临床基因组合作关系

2022-09-011
OAAI
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer
2021-09-0129
OAAI
Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus

SWI/SNF复合物成员DPF3的调节改变是14q24肾癌易感性位点的基础

2021-09-0115
OAAI
Transcriptional mediators of treatment resistance in lethal prostate cancer
2021-03-04101
OAAI
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
2021-02-0599
OAAI